Factors influencing the cardiometabolic response to (poly)phenols and phytosterols: a review of the COST Action POSITIVe activities

European Journal of Nutrition

Volumn 58, Issue , 2019, Pages 37-47

  Gibney, Eileen R ^a   Milenkovic, Dragan ^b   Combet, Emilie ^c   Ruskovska, Tatjana ^d   Greyling, Arno ^e   González Sarrías, Antonio ^f   de Roos, Baujke ^g   Tomás Barberán, Francisco ^f   Morand, Christine ^b   Rodriguez Mateos, Ana ^h  

^a UNIVERSITY COLLEGE DUBLIN   (Ireland)

^b INRA and University of Auvergne   (France)

^c UNIVERSITY OF GLASGOW   (United Kingdom)

^d Faculty of Medical Sciences   (Macedonia)

^e UNILEVER RESEARCH VLAARDINGEN   (Netherlands)

^f RESEARCH GROUP ON QUALITY   (Spain)

^g ROWETT RESEARCH INSTITUTE   (United Kingdom)

^h KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Bioactive; Cardiometabolic diseases; Diet; Gene expression; Health; Metabolism; Metabotype; Microbiome; Plant; Response; Variation

Indexed keywords

PHYTOSTEROL; POLYPHENOL;

CARDIOMETABOLIC RISK; CLINICIAN; DIETITIAN; FOOD INDUSTRY; FOOD INTAKE; HUMAN; INTESTINE FLORA; META ANALYSIS (TOPIC); NONHUMAN; PLANT; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; BIOLOGICAL VARIATION; CARDIOVASCULAR SYSTEM; EDIBLE PLANT; EUROPE; META ANALYSIS; METABOLISM; METABOLOMICS; PHYSIOLOGY; PROCEDURES; VEGETARIAN DIET;

BIOLOGICAL VARIATION, POPULATION; CARDIOVASCULAR SYSTEM; DIET, VEGETARIAN; EUROPE; HUMANS; METABOLOMICS; PHYTOSTEROLS; PLANTS, EDIBLE; POLYPHENOLS;

EID: 85071760540     PISSN: 14366207     EISSN: 14366215     Source Type: Journal    
DOI: 10.1007/s00394-019-02066-6     Document Type: Review

References (59)

1. WHO (2018) Noncommunicable diseases country profiles. WHO, Geneva
2. Mozaffarian D, Benjamin EJ, Go AS, Arnett DK, Blaha MJ, Cushman M, Das SR, de Ferranti S, Després JP, Fullerton HJ, Howard VJ (2016) Heart disease and stroke statistics—2016 update a report from the American Heart Association. Circulation 133(4):e38–e48
3. Satija A, Bhupathiraju SN, Rimm EB, Spiegelman D, Chiuve SE, Borgi L, Willett WC, Manson JE, Sun Q, Hu FB (2016) Plant-based dietary patterns and incidence of type 2 diabetes in US men and women: results from three prospective cohort studies. PLoS Med 13(6):1
4. Aune D, Giovannucci E, Boffetta P, Fadnes LT, Keum N, Norat T, Greenwood DC, Riboli E, Vatten LJ, Tonstad S (2017) Fruit and vegetable intake and the risk of cardiovascular disease, total cancer and all-cause mortality—a systematic review and dose–response meta-analysis of prospective studies. Int J Epidemiol 46(3):1029–1056
5. Katz D, Meller S (2014) Can we say what diet is best for health? Annu Rev Public Health 35:83–103
6. Dillard CJ, German JB (2000) Phytochemicals: nutraceuticals and human health. J Sci Food Agric 80(12):1744–1756
7. Dinkova-Kostova AT, Kostov RV (2012) Glucosinolates and isothiocyanates in health and disease. Trends Mol Med 18(6):337–347
8. Barros MP, Rodrigo MJ, Zacarias L (2018) Dietary carotenoid roles in redox homeostasis and human health. J Agric Food Chem 66(23):5733–5740
9. Del Rio D, Rodriguez-Mateos A, Spencer JP, Tognolini M, Borges G, Crozier A (2013) Dietary (poly) phenolics in human health: structures, bioavailability, and evidence of protective effects against chronic diseases. Antioxidants Redox Signal 18(14):1818–1892
10. Holst B, Williamson G (2008) Nutrients and phytochemicals: from bioavailability to bioefficacy beyond antioxidants. Curr Opin Biotechnol 19(2):73–82
11. Liu XM, Liu YJ, Huang Y, Yu HJ, Yuan S, Tang BW, Wang PG, He QQ (2017) Dietary total flavonoids intake and risk of mortality from all causes and cardiovascular disease in the general population: a systematic review and meta-analysis of cohort studies. Mol Nutr Food Res 61(6):1601003
12. Rienks J, Barbaresko J, Oluwagbemigun K, Schmid M, Nöthlings U (2018) Polyphenol exposure and risk of type 2 diabetes: dose–response meta-analyses and systematic review of prospective cohort studies. Am J Clin Nutr 108(1):49–61
13. Shen J, Wilmot KA, Ghasemzadeh N, Molloy DL, Burkman G, Mekonnen G, Gongora MC, Quyyumi AA, Sperling LS (2015) Mediterranean dietary patterns and cardiovascular health. Annu Rev Nutr 35:425–449
14. Demonty I, Ras RT, van der Knaap HC, Duchateau GS, Meijer L, Zock PL, Geleijnse JM, Trautwein EA (2008) Continuous dose–response relationship of the LDL-cholesterol—lowering effect of phytosterol intake. J Nutr 139(2):271–284
15. Calpe-Berdiel L, Escolà-Gil JC, Blanco-Vaca F (2009) New insights into the molecular actions of plant sterols and stanols in cholesterol metabolism. Atherosclerosis 203(1):18–31
16. Habauzit V, Morand C (2012) Evidence for a protective effect of polyphenolscontaining foods on cardiovascular health: an update for clinicians. Ther Adv Chronic Dis 3:87–106
17. Cicero AF, Fogacci F, Colletti A (2017) Food and plant bioactives for reducing cardiometabolic disease risk: an evidence based approach. Food Funct 8(6):2076–2088
18. Kerimi A, Williamson G (2016) At the interface of antioxidant signalling and cellular function: key polyphenol effects. Mol Nutr Food Res 60(8):1770–1788
19. Krga I, Milenkovic D, Morand C, Monfoulet LE (2016) An update on the role of nutrigenomic modulations in mediating the cardiovascular protective effect of fruit polyphenols. Food Funct 7(9):3656–3676
20. Cardona F, Andrés-Lacueva C, Tulipani S, Tinahones FJ, Queipo-Ortuño MI (2013) Benefits of polyphenols on gut microbiota and implications in human health. J Nutr Biochem 24(8):1415–1422
21. Espín JC, González-Sarrías A, Tomás-Barberán FA (2017) The gut microbiota: a key factor in the therapeutic effects of (poly)phenols. Biochem Pharmacol 139:82–93
22. Tierney AC, McMonagle J, Shaw DI, Gulseth HL, Helal O, Saris WHM, Paniagua JA, Gołąbek-Leszczyñska I, Defoort C, Williams CM, Karsltröm B (2011) Effects of dietary fat modification on insulin sensitivity and on other risk factors of the metabolic syndrome—LIPGENE: a European randomized dietary intervention study. Int J Obes 35(6):800
23. Manach C, Milenkovic D, Van de Wiele T, Rodriguez-Mateos A, De Roos B, Garcia-Conesa MT, Landberg R, Gibney ER, Heinonen M, Tomás-Barberán F, Morand C (2017) Addressing the inter-individual variation in response to consumption of plant food bioactives: towards a better understanding of their role in healthy aging and cardiometabolic risk reduction. Mol Nutr Food Res 61(6):1600557
24. Cassidy A, Minihane AM (2016) The role of metabolism (and the microbiome) in defining the clinical efficacy of dietary flavonoids. Am J Clin Nutr 105(1):10–22
25. Tomás-Barberán FA, Selma MV, Espín JC (2016) Interactions of gut microbiota with dietary polyphenols and consequences to human health. Curr Opin Clin Nutr Metab Care 19(6):471–476
26. Milenkovic D, Morand C, Cassidy A, Konic-Ristic A, Tomás-Barberán F, Ordovas JM, Kroon P, De Caterina R, Rodriguez-Mateos A (2017) Interindividual variability in biomarkers of cardiometabolic health after consumption of major plant-food bioactive compounds and the determinants involved. Adv Nutr 8(4):558–570
27. Bayram B, González-Sarrías A, Istas G, Garcia-Aloy M, Morand C, Tuohy K, García-Villalba R, Mena P (2018) Breakthroughs in the health effects of plant food bioactives: a perspective on microbiomics, nutri (epi) genomics, and metabolomics. J Agric Food Chem 66(41):10686–10692
28. Menezes R, Rodriguez-Mateos A, Kaltsatou A, González-Sarrías A, Greyling A, Giannaki C, Andres-Lacueva C, Milenkovic D, Gibney E, Dumont J, Schär M, Garcia-Aloy A, Palma-Duran SA, Ruskovska T, Maksimova V, Combet E, Pinto P (2017) Impact of flavonols on cardiometabolic biomarkers: a meta-analysis of randomized controlled human trials to explore the role of inter-individual variability. Nutrients 9(2):117
29. González-Sarrías A, Combet E, Pinto P, Mena P, Dall’Asta M, Garcia-Aloy M, Rodríguez-Mateos A, Gibney ER, Dumont J, Massaro M, Sánchez-Meca J, Morand C, Garcia-Conesa MT (2017) A systematic review and meta-analysis of the effects of flavanol-containing tea, cocoa and apple products on body composition and blood lipids: exploring the factors responsible for variability in their efficacy. Nutrients 9(7):1
30. García-Conesa MT, Chambers K, Combet E, Pinto P, Garcia-Aloy M, Andrés-Lacueva C, de Pascual-Teresa S, Mena P, Konic Ristic A, Hollands W, Kroon P, Rodríguez-Mateos A, Istas G, Kontogiorgis CA, Rai DK, Gibney ER, Morand C, Espín JC, González-Sarrías A (2018) Meta-analysis of the effects of foods and derived products containing ellagitannins and anthocyanins on cardiometabolic biomarkers: analysis of factors influencing variability of the individual responses. Int J Mol Sci 19(3):694
31. Alshammari N, Palma-Duran SA, Jiang G, González-Sarrías A, Pinto P, Garcia-Aloy M, Gibney E, García-Conesa MT, Kroon P, Ristić AK, Katsaltou A, Morand C, Rodriguez-Mateos A, Combet E (2018) A systematic review and meta-analysis of randomized controlled trials exploring the role of inter-individual variability on the effect of flavanols on insulin and HOMA-IR. Proc Nutr Soc 77:OCE2
32. Livny O, Reifen R, Levy I, Madar Z, Faulks R, Southon S, Schwartz B (2003) Beta-carotene bioavailability from differently processed carrot meals in human ileostomy volunteers. Eur J Nutr 42(6):338–345
33. Hedren E, Diaz V, Svanberg U (2002) Estimation of carotenoid accessibility from carrots determined by an in vitro digestion method. Eur J Clin Nutr 56(5):425–430
34. Arumugam M, Raes J, Pelletier E, Le Paslier D, Yamada T, Mende DR, Fernandes GR, Tap J, Bruls T, Batto JM, Bertalan M (2011) Enterotypes of the human gut microbiome. Nature 473(7346):174
35. Yatsunenko T, Rey FE, Manary MJ, Trehan I, Dominguez-Bello MG, Contreras M, Magris M, Hidalgo G, Baldassano RN, Anokhin AP, Heath AC (2012) Human gut microbiome viewed across age and geography. Nature 486(7402):222
36. Vandeputte D, Kathagen G, Dhoe K, Vieira-Silva S, Valles-Colomer M, Sabino J, Wang J, Tito RY, De Commer L, Darzi Y, Vermeire S (2017) Quantitative microbiome profiling links gut community variation to microbial load. Nature 551(7681):507
37. Rowland IR, Wiseman H, Sanders TA, Adlercreutz H, Bowey EA (2000) Interindividual variation in metabolism of soy isoflavones and lignans: influence of habitual diet on equol production by the gut microflora. Nutr Cancer 36(1):27–32
38. Bolca S, Possemiers S, Herregat A, Huybrechts I, Heyerick A, De Vriese S, Verbruggen M, Depypere H, De Keukeleire D, Bracke M, De Henauw S (2007) Microbial and dietary factors are associated with the equol producer phenotype in healthy postmenopausal women. J Nutr 137(10):2242–2246
39. Aschoff JK, Riedl KM, Cooperstone JL, Högel J, Bosy-Westphal A, Schwartz SJ, Carle R, Schweiggert RM (2016) Urinary excretion of Citrus flavanones and their major catabolites after consumption of fresh oranges and pasteurized orange juice: a randomized cross-over study. Mol Nutr Food Res 60(12):2602–2610
40. Vallejo FL, Escudero E, Zafrilla MP, Cerdá B, Boza J, García-Conesa MT, Espín JC, Tomás-Barberán FA (2010) The concentration and solubility of flavanones in orange beverages affect their bioavailability in humans. J Agri Food Chem 58:6516–6524
41. Rowland I, Gibson G, Heinken A, Scott K, Swann J, Thiele I, Tuohy K (2018) Gut microbiota functions: metabolism of nutrients and other food components. Eur J Nutr 57(1):1–24
42. Kreijkamp-Kaspers S, Kok L, Bots ML, Grobbee DE, Lampe JW, van der Schouw YT (2005) Randomized controlled trial of the effects of soy protein containing isoflavones on vascular function in postmenopausal women. Am J Clin Nutr 81(1):189–195
43. Hazim S, Curtis PJ, Schär MY, Ostertag LM, Kay CD, Minihane AM, Cassidy A (2016) Acute benefits of the microbial-derived isoflavone metabolite equol on arterial stiffness in men prospectively recruited according to equol producer phenotype: a double-blind randomized controlled trial. Am J Clin Nutr 103(3):694–702
44. González-Sarrías A, Espín JC, Tomás-Barberán FA (2017) Non-extractable polyphenols produce gut microbiota metabolites that persist in circulation and show anti-inflammatory and free radical-scavenging effects. Trends Food Sci Technol 69:281–288
45. Istas G, Feliciano RP, Weber T, Garcia-Villalba R, Tomas-Barberan F, Heiss C, Rodriguez-Mateos A (2018) Plasma urolithin metabolites correlate with improvements in endothelial function after red raspberry consumption: a double-blind randomized controlled trial. Arch Biochem Biophys 651:43–51
46. Kang C, Zhang Y, Zhu X, Liu K, Wang X, Chen M, Wang J, Chen H, Hui S, Huang L, Zhang Q (2016) Healthy subjects differentially respond to dietary capsaicin correlating with specific gut enterotypes. J Clin Endocrinol Metab 101(12):4681–4689
47. Mauray A, Felgines C, Morand C, Mazur A, Scalbert A (2012) Milenkovic D (2012) Bilberry anthocyanin-rich extract alters expression of genes related to atherosclerosis development in aorta of apo E-deficient mice. Nutr Metab Cardiovasc Dis 22(1):72–80
48. Han H, Cui W, Wang L, Xiong Y, Liu L, Sun X, Hao L (2015) Lutein prevents high fat diet-induced atherosclerosis in ApoE-deficient mice by inhibiting NADPH oxidase and increasing PPAR expression. Lipids 50(3):261–273
49. Bai SK, Lee SJ, Na HJ, Ha KS, Han JA, Lee H, Kwon YG, Chung CK, Kim YM (2005) β-Carotene inhibits inflammatory gene expression in lipopolysaccharide-stimulated macrophages by suppressing redox-based NF-κB activation. Exp Mol Med 37(4):323
50. Milenkovic D, Berghe WV, Morand C, Claude S, Van de Sandt A, Gorressen S, Monfoulet LE, Chirumamilla CS, Declerck K, vel Szic KS (2018) A systems biology network analysis of nutri (epi) genomic changes in endothelial cells exposed to epicatechin metabolites. Sci Rep 2018:8
51. deLuis DA, Aller R, Izaola O, Sagrado MG, Conde R (2013) Role of G308 promoter variant of tumor necrosis factor alpha gene on weight loss and metabolic parameters after a high monounsaturated versus a high polyunsaturated fat hypocaloric diets. Med Clin 141(5):189–193
52. Oki E, Norde MN, Carioca AA, Souza JM, Castro IA, Marchioni DM, Fisberg RM, Rogero MM (2017) Polymorphisms of the TNF-α gene interact with plasma fatty acids on inflammatory biomarker profile: a population-based, cross-sectional study in São Paulo, Brazil. Br J Nutr 117(12):1663–1673
53. Welch RW, Berta JL, Bub A, de Vries J, Guarner F, Hasselwander O, Hendriks H, Jakel M, Koletzko BV, Patterson CC, Richelle M, Skarp M, Theis S, Vidry S, Woodside JV (2011) Guidelines for the design, conduct and reporting of human intervention studies to evaluate the health benefits of foods. Br J Nutr 106(S2):S3–S15
54. Kirwan L, Celis-Morales C, Marsaux CF, Livingstone KM, Navas-Carretero S, Fallaize R, O’Donovan CB, Woolhead C, Forster H, Kolossa S, Daniel H, Moschonis G, Manios Y, Surwillo A, Godlewska M, Traczyk I, Drevon CA, Gibney MJ, Lovegrove JA, Martinez JA, Saris WH, Mathers JC, Gibney ER, Brennan L (2016) Phenotypic factors influencing the variation in response of circulating cholesterol level to personalised dietary advice in the Food4Me study. Br J Nutr 116(12):2011–2019
55. Morris C, O’Grada C, Ryan M, Roche HM, Gibney MJ, Gibney ER, Brennan L (2013) Identification of differential responses to an oral glucose tolerance test in healthy adults. PloS one 8(8):72890
56. Osullivan A, Gibney MJ, Connor AO, Mion B, Kaluskar S, Cashman KD, Flynn A, Shanahan F, Brennan L (2011) Biochemical and metabolomic phenotyping in the identification of a vitamin D responsive metabotype for markers of the metabolic syndrome. Mol Nutr Food Res 55(5):679–690
57. Wilson CP et al (2013) Blood pressure in treated hypertensive individuals with the MTHFR 677TT genotype is responsive to intervention with riboflavin: findings of a targeted randomized trial. Hypertension 61(6):1302–1308
58. Ordovas JM, Ferguson LR, Tai ES, Mathers JC (2018) Personalised nutrition and health. BMJ 361:k2173
59. Celis-Morales C, Marsaux CF, Macready AL, Fallaize R, O’Donovan CB, Woolhead C, Forster H, Walsh MC, Navas-Carretero S, San-Cristobal R, Tsirigoti L, Lambrinou CP, Mavrogianni C, Moschonis G, Kolossa S, Hallmann J, Godlewska M, Surwillo A, Traczyk I, Drevon CA, Bouwman J, van Ommen B, Grimaldi K, Parnell LD, Matthews JN, Manios Y, Daniel H, Martinez JA, Lovegrove JA, Gibney ER, Brennan L, Saris WH, Gibney M, Mathers JC (2016) Effect of personalized nutrition on health-related behaviour change: evidence from the Food4me European randomized controlled trial. Int J Epidemiol 46(2):578–588